Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 272 of 272 entries
View as:

Switching From Octreotide to Lanreotide - A Look Back at Patients With Neuroendocrine Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03112694 Org: User:
Start: 04/04/17 End: 11/02/17 Due: 11/02/18

Dysport® Pediatric Lower Limb Spasticity Study

Phase: N/A Priority: Normal
NCT ID: NCT01249417 Org: User:
Start: 07/31/11 End: 06/30/14 Due: 06/30/15

Study to Evaluate the Use of Resources and the Costs Associated With Carcinoid Syndrome (CS) in Patients With NETs in Spain

Phase: N/A Priority: Normal
NCT ID: NCT03220087 Org: User:
Start: 07/21/17 End: 04/30/18 Due: 04/30/19

A Post Marketing Surveillance Study for NutropinAq® in Adults With Growth Hormone Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT00455884 Org: User:
Start: 06/30/06 End: 12/31/11 Due: 12/31/12

Study to Document the Effectiveness of Dysport in Patients Suffering From Upper Limb Spasticity (ULS) After Stroke

Phase: N/A Priority: Normal
NCT ID: NCT02444494 Org: User:
Start: 03/31/15 End: 09/30/16 Due: 09/30/17

Therapeutic Strategies in Acromegalic Subjects Treated With Lanreotide 120mg

Phase: N/A Priority: Normal
NCT ID: NCT02698384 Org: User:
Start: 01/31/16 End: 06/30/16 Due: 06/30/17

A Study to Assess Neuroendocrine Tumour (NET) Patients Currently Treated by Somatuline Autogel for History of Carcinoid Syndrome Associated With Episodes of Diarrhea

Phase: N/A Priority: Normal
NCT ID: NCT01234168 Org: User:
Start: 10/31/10 End: 12/31/12 Due: 12/31/13

Efficacy and Safety of DYSPORT® Using 2mL Dilution in Adults With Cervical Dystonia.

Phase: N/A Priority: Normal
NCT ID: NCT01753310 Org: User:
Start: 01/31/13 End: 01/31/15 Due: 01/31/16

Study to Evaluate the Presence of Lower Urinary Tract Symptoms (LUTS) in Prostate Cancer Patients Scheduled to Receive Luteinizing Hormone Releasing Hormone (LHRH) Analogues

Phase: N/A Priority: Normal
NCT ID: NCT02542501 Org: User:
Start: 07/31/15 End: 07/21/18 Due: 07/21/19

Evaluate the Safety, Tolerability, Biodistribution and Anti Tumour Activity of 177LU-OPS201 With Companion Imaging 68Ga-OPS202 PET/CT in Previously Treated Subjects With Locally Advanced or Metastatic Cancers Expressing Somatostatin Receptor 2 (SSTR2)

Phase: N/A Priority: Normal
NCT ID: NCT03773133 Org: User:
Start: 05/14/19 End: 10/10/19 Due: 10/10/20

Predictive Value of the Insulin-like Growth Factor-1 (IGF-1) Generation Test for the Growth Response to Growth Hormone Treatment (PRED-IGF)

Phase: N/A Priority: Normal
NCT ID: NCT01438801 Org: User:
Start: 05/31/13 End: 05/31/13 Due: 05/31/14

Study to Assess the Efficacy of an Extended Injection Interval Schedule of Lanreotide Autogel in Acromegalic Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00701363 Org: User:
Start: 10/31/08 End: 05/31/13 Due: 05/31/14

Study Assessing Adult Subjects Affected With Upper and/or Lower Limb Spasticity Treated With Botulinum Neurotoxin Type A

Phase: N/A Priority: Normal
NCT ID: NCT04340336 Org: User:
Start: 07/21/20 End: 10/31/21 Due: 10/31/22

Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate

Phase: N/A Priority: Normal
NCT ID: NCT05590793 Org: User:
Start: 11/17/22 End: 08/20/24 Due: 08/20/25

Effect of 120mg Somatuline Autogel at Different Dose Intervals (28, 42 or 56 Days) in Patients With Acromegaly

Phase: N/A Priority: Normal
NCT ID: NCT00444873 Org: User:
Start: 01/31/05 End: 01/31/08 Due: 01/31/09

Long-Term Treatment With rhIGF-1 in GHIS

Phase: N/A Priority: Normal
NCT ID: NCT00571727 Org: User:
Start: 05/20/91 End: 12/15/11 Due: 12/15/12

Assessment of Effectiveness and Safety of Dysport® for the Treatment of Hemifacial Spasm

Phase: N/A Priority: Normal
NCT ID: NCT00276315 Org: User:
Start: 12/31/05 End: 01/31/07 Due: 01/31/08

Factors Influencing Response to One BoNT-A Injection Cycle in Subjects Suffering From Idiopathic Cervical Dystonia

Phase: N/A Priority: Normal
NCT ID: NCT00833196 Org: User:
Start: 02/28/09 End: 04/30/10 Due: 04/30/11

Study To Assess Renewal Of Treatment In Patients Recently Diagnosed With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02238366 Org: User:
Start: 11/30/13 End: 06/06/19 Due: 06/06/20

Botulinum Toxin A Associated Costs in the Treatment of Upper Limb Spasticity Post Stroke

Phase: N/A Priority: Normal
NCT ID: NCT02384330 Org: User:
Start: 11/30/14 End: 03/16/17 Due: 03/16/18

A Study to Evaluate the Effect of Food on the Level of Circulating Elafibranor in Healthy Participants After Intake of a Single Tablet

Phase: N/A Priority: Normal
NCT ID: NCT05564208 Org: User:
Start: 10/27/22 End: 01/14/23 Due: 01/14/24

SAGIT for Classification of Patients With Acromegaly in Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT02231593 Org: User:
Start: 02/28/13 End: 05/31/14 Due: 05/31/15